Sharechat Logo

Australia's HRL Holdings to buy Precise Consulting

Wednesday 24th December 2014

Text too small?

HRL Holdings, the ASX-listed geothermal exploration company, has agreed to buy Precise Consulting, a hazardous material testing laboratory, for $5 million plus any earnout considerations. 

The Queensland-based company will pay up to an earnout consideration of up to $2.5 million for the Christchurch-based lab services company, if it delivers more than $2.5 million in earnings before interest and tax in the year ended Dec. 31, 2015, HRL said in a statement to the ASX. The sale is dependent on ASX and Australian Securities and Investment Commission, shareholder approval and HRL gaining finance to fund the acquisition, via debt, a non-renounceable rights issue and from working capital.

The acquisition is part of HRL's plans to push into the "fast growing New Zealand market" and complements the Australian company's earlier purchase of OCTIEF, which is an "Australian multidisciplinary consulting group specializing in helping organisations maintain Environmental and Occupational compliance, and manage related risks," according to the company's website. Precise specialises in asbestos testing and monitoring as well as other "occupational hygiene issues". 

Upon completion of the purchase, Precise's current owner Andre Halkyard will become general manager for a minimum of three years and the existing employees will remain.

 

 

 

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors